本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

7.26
+0.34004.91%
盤後7.300.0397+0.55%18:32 EDT
成交量:122.78萬
成交額:882.26萬
市值:1.40億
市盈率:-1.19
高:7.50
開:6.86
低:6.82
收:6.92
52周最高:20.56
52周最低:6.33
股本:1,934.13萬
流通股本:1,741.65萬
量比:0.38
換手率:7.05%
股息:- -
股息率:- -
每股收益(TTM):-6.0889
每股收益(LYR):-5.9000
淨資產收益率:-95.58%
總資產收益率:-53.00%
市淨率:1.37
市盈率(LYR):-1.23

資料載入中...

2022/04/11

重要事件披露

8-K - Current report
2022/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/08

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/08

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/12/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/24

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/06/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/01

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report